Anastellin, a Fragment of the First Type III Repeat of Fibronectin, Inhibits Extracellular Signal-Regulated Kinase and Causes G1 Arrest in Human Microvessel Endothelial Cells

Anthony Ambesi(Albany Medical Center Hospital), Paula J. McKeown‐Longo(Albany Medical Center Hospital)

Cancer Research

January 1, 2005

10.1158/0008-5472.148.65.1

Cited by 52

Related Papers

Regulation of the Innate Immune Response by Fibronectin: Synergism between the III-1 and EDA Domains

|PLoS ONE|2014|95

The fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells

|BMC Cancer|2016|27

Fibronectin in the Tumor Microenvironment Activates a TLR4-dependent Inflammatory Response in Lung Cancer Cells

|Journal of Cancer|2020|14